Treace Medical Concepts (TMCI) Other financing activities (2020 - 2026)
Treace Medical Concepts (TMCI) posted Other financing activities of $91000.0 for Q1 2026, up 119.12% on a QoQ basis from -$476000.0 in Q4 2025, and down 23.53% year-over-year from $119000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Other financing activities (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Other financing activities history runs 7 years deep, the most recent figure standing at $91000.0 for Q1 2026.
- Quarterly Other financing activities fell 23.53% year-over-year to $91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28000.0 (down 141.79% YoY) and the FY2023 annual result came in at $107.5 million, changed N/A from the prior year.
- Other financing activities was $91000.0 for Q1 2026 at Treace Medical Concepts, up from -$476000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $107.5 million in Q1 2023 and bottomed at -$105.8 million in Q3 2023.
- A 5-year average of $6.7 million and a median of $117500.0 in 2025 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 7737.24% in 2023, while the deepest fall reached 30081.87% in 2023.
- Treace Medical Concepts' Other financing activities stood at -$1.9 million in 2022, then soared by 5699.79% to $105.8 million in 2023, then sank by 100.35% to -$371000.0 in 2024, then dropped by 28.3% to -$476000.0 in 2025, then jumped by 119.12% to $91000.0 in 2026.
- Business Quant data shows TMCI's Other financing activities at $91000.0 in Q1 2026, -$476000.0 in Q4 2025, and $241000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | -476,000.00 |
| Dec 31, 2025 | -476,000.00 |
| Sep 30, 2025 | 241,000.00 |
| Sep 30, 2025 | 241,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 311,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 105.84 Mn |
| Dec 31, 2023 | 105.84 Mn |